CVS Health Corporation (CVS)
NYSE: CVS · Real-Time Price · USD
53.15
+0.53 (1.01%)
At close: Jan 21, 2025, 4:00 PM
53.24
+0.09 (0.17%)
After-hours: Jan 21, 2025, 7:46 PM EST
CVS Health Revenue
CVS Health had revenue of $94.88B in the quarter ending September 30, 2024, with 6.02% growth. This brings the company's revenue in the last twelve months to $367.25B, up 5.96% year-over-year. In the year 2023, CVS Health had annual revenue of $356.62B with 10.88% growth.
Revenue (ttm)
$367.25B
Revenue Growth
+5.96%
P/S Ratio
0.18
Revenue / Employee
$1,224,153
Employees
300,000
Market Cap
66.88B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 356.62B | 34.99B | 10.88% |
Dec 31, 2022 | 321.63B | 30.72B | 10.56% |
Dec 31, 2021 | 290.91B | 23.00B | 8.59% |
Dec 31, 2020 | 267.91B | 12.14B | 4.75% |
Dec 31, 2019 | 255.77B | 61.85B | 31.89% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 87.70B |
Merck & Co. | 63.17B |
AbbVie | 55.53B |
AstraZeneca | 51.21B |
Novartis AG | 49.94B |
Thermo Fisher Scientific | 42.37B |
Abbott Laboratories | 41.22B |
CVS News
- 19 hours ago - Rose's Income Garden Portfolio Revealed: Yield 6.2%/Defensive Sector Winners - Seeking Alpha
- 5 days ago - CVS Health Isn't Going To The Dogs - Seeking Alpha
- 7 days ago - These two-dozen value stocks are poised to lead the stock market - Market Watch
- 8 days ago - CVS Health to hold fourth quarter and full year 2024 earnings conference call - PRNewsWire
- 8 days ago - CVS Health stock price rises after Walgreens earnings: is it a buy? - Invezz
- 11 days ago - CVS Health supporting customers, patients, members and colleagues amid California wildfires - PRNewsWire
- 11 days ago - CVS Health: An Attractive 5.8% Safe Yield For Now - Seeking Alpha
- 15 days ago - This Stock Has A 5.81% Yield And Sells For Less Than Book - Forbes